前收市價 | 25.06 |
開市 | 25.06 |
買盤 | 24.44 x 300 |
賣出價 | 24.54 x 300 |
今日波幅 | 23.11 - 25.22 |
52 週波幅 | 20.84 - 34.28 |
成交量 | |
平均成交量 | 1,097,712 |
市值 | 2.553B |
Beta 值 (5 年,每月) | 0.48 |
市盈率 (最近 12 個月) | 23.35 |
每股盈利 (最近 12 個月) | 1.05 |
業績公佈日 | 2024年7月31日 - 2024年8月05日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 43.60 |
Corcept (CORT) beats on both earnings and sales in the first quarter of 2024. The company increases revenue guidance for 2024.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript May 1, 2024 Corcept Therapeutics Incorporated beats earnings expectations. Reported EPS is $0.2503, expectations were $0.21. Corcept Therapeutics Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank […]
Corcept (CORT) reports positive data from the open-label portion of the phase III GRACE study evaluating relacorilant for treating patients with Cushing's syndrome.